In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Adults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy offers significant glycemic benefits for individuals with ...